TESTOSTERONE CYPIONATE

N/A

Manufactured by Pharmacia & Upjohn Company LLC

15,890 FDA adverse event reports analyzed

Last updated: 2026-04-14

About TESTOSTERONE CYPIONATE

TESTOSTERONE CYPIONATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Pharmacia & Upjohn Company LLC. The most commonly reported adverse reactions for TESTOSTERONE CYPIONATE include MYOCARDIAL INFARCTION, CEREBROVASCULAR ACCIDENT, DEEP VEIN THROMBOSIS, DRUG INEFFECTIVE, PULMONARY EMBOLISM. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TESTOSTERONE CYPIONATE.

Top Adverse Reactions

MYOCARDIAL INFARCTION947 reports
CEREBROVASCULAR ACCIDENT682 reports
DEEP VEIN THROMBOSIS619 reports
DRUG INEFFECTIVE579 reports
PULMONARY EMBOLISM553 reports
PAIN473 reports
FATIGUE453 reports
ANXIETY360 reports
PRODUCT DOSE OMISSION ISSUE349 reports
THROMBOSIS344 reports
PRODUCT DEPOSIT308 reports
INJECTION SITE PAIN286 reports
OFF LABEL USE284 reports
ASTHENIA261 reports
DYSPNOEA243 reports
DEPRESSION239 reports
POOR QUALITY PRODUCT ADMINISTERED238 reports
HEADACHE229 reports
ACUTE MYOCARDIAL INFARCTION225 reports
CARDIOVASCULAR DISORDER225 reports
LIQUID PRODUCT PHYSICAL ISSUE217 reports
CARDIAC FAILURE CONGESTIVE201 reports
NAUSEA198 reports
FEELING ABNORMAL167 reports
DIARRHOEA164 reports
DIZZINESS154 reports
PAIN IN EXTREMITY152 reports
PRODUCT QUALITY ISSUE151 reports
HYPERTENSION149 reports
PRODUCT USE ISSUE145 reports
CARDIAC DISORDER143 reports
CHEST PAIN141 reports
CORONARY ARTERY DISEASE140 reports
MALAISE137 reports
ARTHRALGIA134 reports
INFARCTION133 reports
QUALITY OF LIFE DECREASED129 reports
ISCHAEMIA127 reports
EMOTIONAL DISTRESS125 reports
BLOOD TESTOSTERONE DECREASED121 reports
WEIGHT DECREASED121 reports
PRODUCT USE IN UNAPPROVED INDICATION120 reports
RASH119 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION114 reports
ATRIAL FIBRILLATION113 reports
MULTIPLE USE OF SINGLE USE PRODUCT112 reports
WEIGHT INCREASED111 reports
COUGH110 reports
FALL110 reports
INSOMNIA108 reports
CONDITION AGGRAVATED107 reports
PNEUMONIA105 reports
BACK PAIN104 reports
DEATH103 reports
TRANSIENT ISCHAEMIC ATTACK103 reports
INJECTION SITE SWELLING101 reports
GAIT DISTURBANCE100 reports
INCORRECT DOSE ADMINISTERED95 reports
ECONOMIC PROBLEM93 reports
MUSCLE SPASMS93 reports
INTENTIONAL PRODUCT USE ISSUE91 reports
VOMITING91 reports
SOMNOLENCE89 reports
MYALGIA88 reports
ANHEDONIA86 reports
COVID 1985 reports
PRURITUS85 reports
AMNESIA83 reports
MEMORY IMPAIRMENT78 reports
BLOOD PRESSURE INCREASED76 reports
PERIPHERAL SWELLING75 reports
ACUTE KIDNEY INJURY74 reports
INJECTION SITE ERYTHEMA74 reports
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION73 reports
INJURY73 reports
PYREXIA73 reports
HYPOAESTHESIA71 reports
POLYCYTHAEMIA71 reports
SLEEP APNOEA SYNDROME71 reports
BLOOD TESTOSTERONE INCREASED69 reports
ERECTILE DYSFUNCTION69 reports
HYPERSENSITIVITY69 reports
CONSTIPATION67 reports
DECREASED APPETITE67 reports
BLOOD GLUCOSE INCREASED64 reports
BURNING SENSATION64 reports
CARDIAC ARREST63 reports
CHRONIC KIDNEY DISEASE63 reports
RENAL FAILURE63 reports
BALANCE DISORDER62 reports
CELLULITIS61 reports
INFECTION61 reports
INJECTION SITE MASS61 reports
PRODUCT ADMINISTRATION ERROR61 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS61 reports
ACTIVITIES OF DAILY LIVING IMPAIRED60 reports
RECALLED PRODUCT ADMINISTERED60 reports
ABDOMINAL DISCOMFORT57 reports
CONFUSIONAL STATE57 reports
MUSCULAR WEAKNESS57 reports

Report Outcomes

Out of 8,494 classified reports for TESTOSTERONE CYPIONATE:

Serious 58.1%Non-Serious 41.9%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male7,260 (93.0%)
Female483 (6.2%)
Unknown67 (0.9%)

Reports by Age

Age 52151 reports
Age 58151 reports
Age 56147 reports
Age 55145 reports
Age 65145 reports
Age 53140 reports
Age 51139 reports
Age 54135 reports
Age 49125 reports
Age 62125 reports
Age 57124 reports
Age 60123 reports
Age 61120 reports
Age 59112 reports
Age 50110 reports
Age 63110 reports
Age 64110 reports
Age 66108 reports
Age 48103 reports
Age 6794 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TESTOSTERONE CYPIONATE?

This profile reflects 15,890 FDA FAERS reports that mention TESTOSTERONE CYPIONATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TESTOSTERONE CYPIONATE?

Frequently reported terms in FAERS include MYOCARDIAL INFARCTION, CEREBROVASCULAR ACCIDENT, DEEP VEIN THROMBOSIS, DRUG INEFFECTIVE, PULMONARY EMBOLISM, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TESTOSTERONE CYPIONATE?

Labeling and FAERS entries often list Pharmacia & Upjohn Company LLC in connection with TESTOSTERONE CYPIONATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.